In-depth biotech analysis articles

In Depth 29 Sep 2023

Illumina: DNA giant in troubled waters

A botched acquisition deal and unrest among company investors amid plummeting stocks have plagued Illumina, which was once part of the biotech big leagues that dominated the field of gene sequencing. Now, in fear of losing its ground to other players in the space, it has received a European Commission order to divest Grail, and […]

September 29, 2023 - 8 minutesmins - By Roohi Mariam Peter

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

The last few months have seen the obesity drug market soar, after new weight loss and diabetes drugs like Novo Nordisk’s Wegovy and Ozempic took the world by storm with their incredible efficacy at inducing weight loss. These new drugs belong to a class of medications called GLP-1 analogs (or incretin-based therapies), which work by […]

September 28, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 25 Sep 2023

Base editing hits the clinic in the U.S.

Over the past couple of years, base editing, a recent offshoot of the heralded CRISPR/Cas 9 technology, has been doing its rounds in the biotech space. Now, base editing has finally set foot into clinical trials for the first time in the U.S.. American precision medicine company Beam Therapeutics treated its first patient with its […]

September 25, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 14 Sep 2023

Righting wrongs: genetic justice for Henrietta Lacks

For what would have been Henrietta Lacks’ 103rd birthday last month, her family, who settled a lawsuit with Thermo Fisher – a multinational biotech company that had used her cells without seeking consent for several years – regarded the win as a “fitting day” for justice. While the settlement took place behind closed doors, where Henrietta […]

September 14, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

With biotech funding trends always evolving, HSBC Innovation Banking’s inaugural Venture Healthcare Report lays out the trends seen in the first half (1H) of 2023, where valuations underwent a necessary reset, and venture capitalists emerged from their cautious stance, eventually embarking on a fresh wave of investments. However, an overall decline in investment was still […]

September 11, 2023 - 5 minutesmins - By Willow Shah-Neville

In Depth 8 Sep 2023

The rise of lab-grown dairy: a sustainable solution for the future

Recently, there has been a lot of talk surrounding cultivated meat, especially after Upside Foods and Good Meat received final U.S. Department of Agriculture (USDA) approval to sell lab-grown meat for the first time in the U.S.. And, although perhaps less talked about, cultivated – or lab-grown – dairy could also be set to take […]

September 8, 2023 - 8 minutesmins - By Willow Shah-Neville

Duchenne muscular dystrophy gene therapy

In Depth 7 Sep 2023

Hope for patients with life-threatening muscle disorder after years of clinical trial failures

Duchenne muscular dystrophy is a rare condition that is typically treated with the help of steroids, to manage symptoms, as scientists are yet to close in on a cure. However, the first-ever gene therapy for Duchenne muscular dystrophy is set to open doors for further therapeutic research. As we observe World Duchenne Awareness Day on […]

September 7, 2023 - 8 minutesmins - By Roohi Mariam Peter

In Depth 4 Sep 2023

The biggest private biotech investments in August 2023

The companies Genesis Therapeutics, ADARx Pharmaceuticals, and Abcuro bagged the biggest biotech investments in August 2023. Around the world, companies focused on immunology, genetic disorders, and metabolic disorders attracted the biggest funding rounds. Overall, quite a lot of biotech fundraising took place in August 2023. As always, there were some big rounds within the U.S. […]

September 4, 2023 - 3 minutesmins - By Willow Shah-Neville

In Depth 31 Aug 2023

3D-printed tumors: startup hopes to drive cancer drug discovery

3D printing is capturing attention in the field of medicine of late. With the first 3D-printed drug being approved for the treatment of seizures, eight years ago, it was a consequential moment in healthcare, following which biotechs raced to step up personalized treatment. Now, with Chinese healthcare company Triastek turning heads after announcing promising clinical […]

August 31, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 24 Aug 2023

Saudi Arabia: is the country set to become a global biotech hub?

Saudi Arabia seems set to become a global competitive biotech hub; over the next decade, it is expected to become a world leader in biotech research and generate significant economic growth. A recent report by Strategy& Middle East, part of the PwC network, entitled “Accelerating Saudi Arabia’s Biotechnology Sector”, suggested that Saudi Arabia has the […]

August 24, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 22 Aug 2023

Lab-grown babies on the horizon: how IVG could transform human reproduction

Lately, there seems to have been a lot of talk about the possibility of ‘lab-grown babies’. Proper research into this area kicked off around a decade ago, and is still largely experimental in humans. But the technique used to potentially develop lab-grown babies could hold the power to provide a novel treatment option for human […]

August 22, 2023 - 8 minutesmins - By Willow Shah-Neville

In Depth 16 Aug 2023

Can a vaccine be the solution to the surge in melanoma cases caused by the climate crisis?

Melanoma is the most serious type of skin cancer, and is primarily caused by too much exposure to ultraviolet (UV) light – in the U.K., around 85% of melanomas are thought to be caused by too much ultraviolet radiation. And, unfortunately, because of this, the surge in global temperatures caused by the climate crisis is […]

August 16, 2023 - 7 minutesmins - By Willow Shah-Neville

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us